Teva’s Asthma Drug ‘Significantly’ Improves Lung Function In Phase 3 Trials – NASDAQ

Teva's Asthma Drug 'Significantly' Improves Lung Function In Phase 3 Trials
NASDAQ
(RTTNews.com) – Teva Pharmaceutical Industries Ltd. ( TEVA ) Monday said asthma patients with elevated eosinophils showed significant improvement in lung function and asthma control after being treated with reslizumab in final-stage studies of the anti …

and more »